NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)
1.54
0.00 (0.00%)
USD |
NASDAQ |
Apr 05, 16:00
NGM Biopharmaceuticals 1 Year Total Returns (Daily): -60.81% for April 5, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 05, 2024 | -60.81% |
April 04, 2024 | -61.11% |
April 03, 2024 | -62.41% |
April 02, 2024 | -61.76% |
April 01, 2024 | -61.76% |
March 28, 2024 | -58.38% |
March 27, 2024 | -58.88% |
March 26, 2024 | -59.21% |
March 25, 2024 | -59.21% |
March 22, 2024 | -59.32% |
March 21, 2024 | -60.41% |
March 20, 2024 | -59.84% |
March 19, 2024 | -58.95% |
March 18, 2024 | -58.95% |
March 15, 2024 | -58.68% |
March 14, 2024 | -60.97% |
March 13, 2024 | -60.36% |
March 12, 2024 | -60.31% |
March 11, 2024 | -60.31% |
March 08, 2024 | -62.03% |
March 07, 2024 | -62.86% |
March 06, 2024 | -64.90% |
March 05, 2024 | -65.85% |
March 04, 2024 | -66.07% |
March 01, 2024 | -67.31% |
Date | Value |
---|---|
February 29, 2024 | -67.93% |
February 28, 2024 | -67.72% |
February 27, 2024 | -64.25% |
February 26, 2024 | -66.78% |
February 23, 2024 | -58.92% |
February 22, 2024 | -59.53% |
February 21, 2024 | -56.85% |
February 20, 2024 | -66.67% |
February 16, 2024 | -67.10% |
February 15, 2024 | -68.30% |
February 14, 2024 | -70.30% |
February 13, 2024 | -71.23% |
February 12, 2024 | -69.72% |
February 09, 2024 | -69.96% |
February 08, 2024 | -71.96% |
February 07, 2024 | -73.47% |
February 06, 2024 | -73.61% |
February 05, 2024 | -74.26% |
February 02, 2024 | -73.08% |
February 01, 2024 | -71.40% |
January 31, 2024 | -70.80% |
January 30, 2024 | -69.06% |
January 29, 2024 | -69.74% |
January 26, 2024 | -71.24% |
January 25, 2024 | -73.18% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.98%
Minimum
Sep 28 2023
203.4%
Maximum
Mar 18 2021
-21.39%
Average
-35.65%
Median
Aug 08 2022
1 Year Total Returns (Daily) Benchmarks
Catalent Inc | 28.16% |
AIM ImmunoTech Inc | -28.75% |
Perspective Therapeutics Inc | 43.01% |
Protalix BioTherapeutics Inc | -44.09% |
Armata Pharmaceuticals Inc | 101.5% |